Trial
NCT05571839
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Seagen, a wholly owned subsidiary of Pfizer
Collaborators
—
Condition
Cutaneous Melanoma
Intervention
PF-08046049
Why stopped
The trial was terminated for strategic reasons. The decision was not based on any safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-01